相关实验视频

Updated: May 14, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

帕金森病模型中的植物性单烯疗法:系统性审查和元分析

Matías Jávega-Cometto¹, Aracely J Naranjo-Viteri¹, Leandro G Champarini¹

¹Instituto de Farmacología Experimental de Córdoba (IFEC-CONICET), Departamento de Farmacología Otto Orsingher, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba X5000HUA, Argentina.

Plants (Basel, Switzerland)

|April 12, 2025

概括

在精油中发现的单烯 (MTs) 通过减少炎症和氧化应激,有望保护人们免受帕金森病 (PD) 的影响. 需要进一步的临床研究来确认它们对PD的治疗潜力.

科学领域:

药理学和神经科学药理学和神经科学
自然产品化学自然产品化学
神经退行性疾病研究研究

背景情况:

单烯 (MTs) 是植物二次代谢物,在精油 (EO) 中丰富,具有制药应用.
帕金森病 (PD) 的特点是渐进的多巴胺基神经元损失,导致运动缺陷.
在PD中MT的神经保护潜力仍然不完全理解.

研究的目的:

在帕金森病的临床前模型中系统地审查和元分析MTs神经保护作用的证据.
为了确定特定的MTs与潜在的治疗益处PD.
阐明MT神经保护作用的基本机制.

主要方法:

在PubMed,SCOPUS,谷歌学者和ScienceDirect进行了系统的文献搜索.
在研究选择和数据提取方面遵循了PRISMA指南.
对30项涉及MTs的选定研究在小鼠PD模型中进行了元分析.

主要成果:

在EO中常见的15种MT被确定为PD的潜在治疗剂.
在帕金森症动物中,MT的使用显著改善了运动性能.
MTs增加了氨酸氧化酶水平,降低了氧化应激 (氨酸),降低了炎症 (IL-6,IL-1,TNF-α),同时增强了抗氧化酶 (catalase,超氧化失调酶).

结论:

MTs具有显著的抗氧化和抗炎性质,对于减轻PD模型中的多巴胺基神经退行至关重要.
这些发现凸显了MTs作为PD新型治疗方法的有希望的候选人.
翻译性研究和临床试验对于验证这些临床前发现对人类应用至关重要.

关键词:

帕金森病的动物模型.行为测试是一种行为测试.单烯是一种单烯.神经炎症是一种神经炎症.氧化应激是一种氧化应激.

更多相关视频

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...